Scientists are working on new insulin-delivery devices at a laboratory Eli Lilly opened in Cambridge in 2015. Scientists are working on new insulin-delivery devices at a laboratory Eli Lilly opened in Cambridge in 2015. In a research laboratory Lilly opened here in 2015, scientists have been developing a wearable, automated insulin-delivery device designed to reduce the decision-making and guesswork of conventional insulin injections. And it sees growth in the market for advanced insulin-delivery devices. “To me, it’s clear where the business is going.” ​Lilly’s insulin products currently generate about 20% of the company’s total revenue.

Source: Wall Street Journal November 21, 2017 12:56 UTC